SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-057870
Filing Date
2019-02-28
Accepted
2019-02-28 17:03:04
Documents
6
Effectiveness Date
2019-02-28

Document Format Files

Seq Description Document Type Size
1 S-8 d714625ds8.htm S-8 37241
2 EX-5.1 d714625dex51.htm EX-5.1 8493
3 EX-23.2 d714625dex232.htm EX-23.2 1674
4 GRAPHIC g714625dsp06.jpg GRAPHIC 1874
5 GRAPHIC g714625dsp06a.jpg GRAPHIC 4724
6 GRAPHIC g714625dsp06b.jpg GRAPHIC 1515
  Complete submission text file 0001193125-19-057870.txt   60024
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-229971 | Film No.: 19644562
SIC: 2834 Pharmaceutical Preparations